Prof. Dr. Klaus Überla



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Characterization of SARS-CoV-2 Escape Mutants to a Pair of Neutralizing Antibodies Targeting the RBD and the NTD (2022) Peter AS, Grüner E, Socher E, Fraedrich K, Richel E, Müller-Schmucker S, Cordsmeier A, et al. Journal article Design and Functional Characterization of HIV-1 Envelope Protein-Coupled T Helper Liposomes (2022) Damm D, Suleiman E, Theobald H, Wagner J, Batzoni M, Kohlhauser BAN, Walkenfort B, et al. Journal article Smaller, Stronger, More Stable: Peptide Variants of a SARS-CoV-2 Neutralizing Miniprotein (2022) Weißenborn L, Richel E, Hueseman H, Welzer J, Beck S, Schäfer S, Sticht H, et al. Journal article Time Trend in SARS-CoV-2 Seropositivity, Surveillance Detection- and Infection Fatality Ratio until Spring 2021 in the Tirschenreuth County—Results from a Population-Based Longitudinal Study in Germany (2022) Einhauser S, Peterhoff D, Beileke S, Günther F, Niller HH, Steininger P, Knöll A, et al. Journal article Reactogenicity after heterologous and homologous COVID-19 prime-boost vaccination regimens: descriptive interim results of a comparative observational cohort study (2022) Warkentin L, Zeschick N, Kühlein T, Steininger P, Überla K, Kaiser I, Gall C, et al. Journal article Continuous monitoring of SARS-CoV-2 seroprevalence in children using residual blood samples from routine clinical chemistry (2022) Wachter F, Regensburger A, Peter AS, Knieling F, Wagner A, Simon D, Hörning A, et al. Journal article Comparative Immunogenicity of COVID-19 Vaccines in a Population-Based Cohort Study with SARS-CoV-2-Infected and Uninfected Participants (2022) Peterhoff D, Einhauser S, Beileke S, Niller HH, Günther F, Schachtner M, Asbach B, et al. Journal article Erratum: Intrastructural Help: Harnessing T Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines (Journal of Virology (2018) 92:14 (e00141-18) Doi:10.1128/JVI.00141-18) (2022) Elsayed H, Nabi G, McKinstry WJ, Khoo KK, Mak J, Salazar AM, Tenbusch M, et al. Journal article, Erratum Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern (2022) Wratil PR, Stern M, Priller A, Willmann A, Almanzar G, Vogel E, Feuerherd M, et al. Journal article Covalent coupling of HIV-1 glycoprotein trimers to biodegradable calcium phosphate nanoparticles via genetically encoded aldehyde-tags (2022) Damm D, Kostka K, Weingärtner C, Wagner J, Rojas-Sánchez L, Gensberger-Reigl S, Sokolova V, et al. Journal article
1 2 3 4 5 ... 9